UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Need cash fast? Explore effective ways to earn money today and improve your financial situation quickly.
23,263 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Spotify unveiled a long-term plan to hit 1 billion active users and sustain 20% operating margins by 2030, highlighti...
In May, Figma delivered a performance surge that surprised many investors. This article breaks down the key drivers b...
As global tensions persist, defense giants report robust backlogs that signal predictable revenue. Here are three hig...
Investors are re-evaluating JEPI after peers showed stronger upside. This report breaks down the real costs behind JE...
In a watershed move, Alphabet will join the Dow, while Verizon exits, as investors weigh AI investments against stead...
PepsiCo is set to report Q2 2026 results before the market opens on July 9, 2026, with a fresh price target and impro...
GPIQ carries the lowest fee in the Nasdaq-100 income ETF group, at 0.29%, intensifying the debate over cost versus yi...
A major fund boosted its Vicor stake, sending the stock higher as a 200% rally unfolds. This article unpacks the bet,...
An Oppenheimer upgrade follows Oracle’s dramatic price drop, suggesting patient investors could access a premier grow...
Gap reports eight straight quarters of positive comps and a multi-decade margin high, prompting a televised reaction ...
When oil surges grab the headlines, it’s easy to assume inflation will follow. In reality, inflation data often reass...